Navigation Links
CETS offers new method to help simplify the study of brain pathologies
Date:2/28/2013

Scientists from the Johns Hopkins University School of Medicine in Baltimore, MD have developed a new way to identify heterogeneous brain cells by looking at epigenetic variation (the heritable alterations in gene expression caused by mechanisms other than changes in DNA sequence). With this publicly available new method (named "CETS"), it will be possible to generate neuronal profiles from DNA methylation data, which will simplify the study of several brain pathologies, including depression and age-associated disorders. The study, titled "A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression," appears in the March 2013 issue of Epigenetics: http://www.landesbioscience.com/journals/epigenetics/article/23924/.


'/>"/>

Contact: Andrew Thompson
andrew@landesbioscience.com
Landes Bioscience
Source:Eurekalert

Page: 1

Related biology news :

1. Experimental gene therapy treatment for Duchenne muscular dystrophy offers hope for youngster
2. Study of human specimen collections in the US offers first look at their huge diversity
3. Dartmouth research offers new control strategies for bipolar bark beetles
4. Study offers new insights into the mechanics of muscle fatigue
5. Gout study offers genetic insight into disease of kings
6. Unraveling the threads: Simplest cotton genome offers clues for fiber improvements
7. Study offers insights into role of muscle weakness in Down syndrome
8. Vaccine offers promise as post-surgery treatment for pancreatic cancer patients
9. CCNY landscape architect offers storm surge defense alternatives
10. Study offers new tool for incorporating water impacts into policy decisions
11. Wake Forest Baptist Offers Tips on How to Avoid and Relieve Campaign Season Stress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2017)... , Feb. 3, 2017 A new independent ... Strategy Partners, LLP (IdSP) . Designed to fill a ... complex identity market, founding partners Mark Crego ... combined years just in identity expertise that span federal ... non-profit leadership. The Crego-Kephart combined expertise has a common ...
(Date:2/2/2017)...  Central to its deep commitment to honor ... Japan Prize Foundation today announced the laureates of ... envelope in their respective fields of Life Sciences ... being recognized with the 2017 Japan Prize for ... to the advancement of science and technology, but ...
(Date:1/30/2017)... --  Invitae Corporation (NYSE: NVTA ), ... announced that it will report its fourth quarter and ... Monday, February 13, 2017, and Invitae,s management team will ... Eastern / 1:45 p.m. Pacific. During ... results, guidance, and recent developments and will spend the ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... Mass. , Feb. 17, 2017  If ... small tumor had a mutation-conferring resistance to chemotherapy, ... Recently, genomics research has focused on finding these ... or even from circulating tumor DNA in blood ... new oncology therapeutics. Unfortunately, however, detecting ...
(Date:2/16/2017)... , Feb. 16, 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), ... system to find a better treatment for triple negative breast ... in France program. The ... an accelerator designed to help entrepreneurs grow their business in ... one of eight American companies selected to complete an intensive ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
(Date:2/16/2017)...  Champions Oncology, Inc. (NASDAQ: CSBR ), ... advanced technology solutions and products to personalize the development ... of new cohorts of PDX models to their existing ... Champions, product line in hepatocellular cancer, breast cancer, castrate ... non-small cell lung cancer (including EGFR mutation; ALK/ROS1 positive) ...
Breaking Biology Technology: